|
Characteristic
|
OR (95 % CI)
|
p-value
|
AOR (95 % CI)
|
p-value
|
|---|
|
IDU transmission
|
117.18 (33.00–416.13)
|
<0.0001
|
46.25 (8.39–254.88)
|
<0.001
|
|
Did not complete high school
|
19.32 (8.32–44.87)
|
<0.0001
|
17.39 (4.45–67.96)
|
<0.001
|
|
Blood transmission
|
0.03 (0.01–0.13)
|
<0.0001
|
0.08 (0.01–0.57)
|
0.005
|
|
HCV genotype 6a
|
6.02 (2.97–12.22)
|
<0.0001
| | |
|
HCV genotype 3a
|
3.83 (1.21–12.14)
|
0.023
| | |
|
Male
|
3.20 (1.62–6.31)
|
0.001
| | |
|
Guangdong province
|
3.07 (1.27–7.41)
|
0.013
| | |
|
Increasing age
|
0.97 (0.94–0.997)
|
0.031
| | |
|
Unknown HCV risk factor
|
0.18 (0.05–0.65)
|
0.009
| | |
|
HCV genotype 1b
|
0.13 (0.07–0.26)
|
<0.0001
|
Model AIC =72.14
|
- Abbreviations: OR odds ratio, AOR adjusted odds ratio, CI confidence interval, IDU intravenous drug use, AIC Aikaike information criteria. Missing data were excluded from statistical analysis. Bold p-values are significant at the 0.05 level
